The bronchodilator test in chronic obstructive pulmonary disease: Interpretation methods

Respiratory Medicine

Volumn 101, Issue 1, 2007, Pages 34-42

  Rodriguez Carballeira M ^a   Heredia, J L ^a   Rue M ^b   Quintana, S ^a   Almagro, P ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Interpretation of bronchodilator test

Indexed keywords

BRONCHODILATING AGENT; PLACEBO; TERBUTALINE;

AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

AGED; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; DATA INTERPRETATION, STATISTICAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY; TERBUTALINE; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 33751516433     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.04.018     Document Type: Article

References (30)

1. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. On behalf of the Task Force. ERS Consensus Statement. Eur Respir J 8 (1995) 1398-1420
2. ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Cirt Care Med 1995;152(Suppl.):S77-S120.
3. Calverly PMA, Burge PS, Spencer S, Anderson JA, Jones PW for de ISOLDE Study Investigators. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-64.
4. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connet JE for the Lung Health Study Research Group. Bronchodilator response in the Lung Health Study over 11 years. Eur Respir J 2005;26:45-51.
5. Nisar M., Walshaw M., Earis J.E., Pearson M.G., and Calverley P.M. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 45 (1990) 190-194
6. Anthonisen NR, Wright EC, IPPB Trial Groups. Response to inhaled bronchodilators in COPD. Chest 1987;91 (5 suppl):36S-9S.
7. Postma D.S., Vries K.D., Koeter G.H., and Sluiter H.J. Independent influence of reversibility of airflow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic airflow obstruction. Am Rev Respir Dis 134 (1986) 276-280
8. Antó J.M., Vermeire P., Vestbo J., and Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 17 (2001) 773-790
9. Xu X., Rijcken B., Schouten J.P., and Weiss S.T. Airways responsiveness and development and remission of chronic respiratory symptoms in adults. Lancet 350 (1997) 1431-1434
10. Harf A. How to express the reversibility of bronchial obstruciton?. Eur Respir J 5 (1992) 919-920
11. Berger R., and Smith D. Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction. Chest 93 3 (1988) 541-546
12. Pennock B.E., Rogers R.M., and McCaffree D.R. Changes in measured spirometric indices. What is significant?. Chest 80 1 (1981) 97-99
13. Rodríguez-Carballeira M., and Heredia J.L. Prueba bronco-dilatadora en pacientes con EPOC. Arch Bronconeumol Clin 36 6 (2000) 334-343
14. Quanjer Ph.H., Tammeling G.S., Cotes J.E., Pedersen O.F., Peslin R., and Yennault J.C. Lung Volumes and forced ventilatory flows. Report working party standardization of lung function tests. European Community for steel and coal. Eur Respir J 6 Suppl. 16 (1993) 5-40
15. Weir D.C., and Burge P.S. Measures of reversibility in response to bronchodilators in chronic airflow obstruciton: relation to airway calibre. Thorax 46 (1991) 35-43
16. 1. Eur Respir J 5 (1992) 975-981
17. Editorial. Predicted values: how should we use them? Thorax 1988;43:265-67.
18. Kerstjens HAM, Brand PLP, Quanjer PH, van der Bruggen-Bogaarts BAHA, Koëter GH, Postma DS on behalf of the Dutch CNSLD Study Group. Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Thorax 1993;48:722-9.
19. Brand P.L., Quanjer P.H., Postma D.S., Kerstjens H.A.M., Koëter G.H., Dekhuijzen P.N.R., et al. and the Dutch chronic non-specific lung disease (CNSLD) study group. Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax 47 (1992) 429-436
20. Committe on emphysema of the American College of Chest Physicians. Criteria for the assessment of reversibility in airways obstruction. Chest 65 5 (1974) 552-553
21. American Thoracic Society. ATS Statement. Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 119 (1979) 831-838
22. Roca J., Sanchis J., Agustí-Vidal A., Segarra F., Navajas D., Rodríguez-Roisín R., et al. Spirometric reference values for a mediterranean population. Bull Eur Physiopathol Respir 22 (1986) 217-224
23. Chinn S. Repeatability and method comparison. Thorax 46 (1991) 454-456
24. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
25. Hanley J.A., and McNeil B.J. A method of comparing the areas under Receiver Operating Characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
26. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 42 (1987) 487-490
27. Sourk R.L., and Nugent K.M. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis 128 (1983) 153-157
28. Nickerson B.G., Lemen R.J., Gerdes C.B., Wegmann M.J., and Robertson G. Within-subject variability and percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 122 (1980) 859-866
29. Barros M.J., and Rees P.J. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med 84 (1990) 311-315
30. Anthonisen NR, Wright EC and the IPPB trial group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:814-9.